Overview and Scope
Intravenous infusion pumps are medical devices used for controlled delivery of drugs into the patient’s body.
Sizing and Forecast
The intravenous infusion pumps market size has grown strongly in recent years. It will grow from <b>$5.71 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. </b> The growth in the historic period can be attributed to advances in medical technology, aging population, home healthcare services, hospital and healthcare facility expansion, regulatory standards.
The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to <b>$8.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. </b> The growth in the forecast period can be attributed to increasing chronic disease burden, technological innovation, home infusion services, telehealth and remote monitoring. Major trends in the forecast period include smart infusion pumps, wireless and remote monitoring, home infusion therapy, precision medicine and personalized infusion.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Segmentation & Regional Insights
The intravenous infusion pumps market covered in this report is segmented –
1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products
2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users
<b>North America</b> was the largest region in the intravenous infusion pumps market in 2023. <b>Western Europe</b> was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of people with chronic pain, cancer, and diabetes is a significant driver of the demand for intravenous infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient’s body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the intravenous infusion pumps market.
Key Industry Players
Major companies operating in the intravenous infusion pumps market include <b>B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation</b>
The intravenous infusion pumps market report table of contents includes:
1. Executive Summary
2. Intravenous Infusion Pumps Market Characteristics
3. Intravenous Infusion Pumps Market Trends And Strategies
4. Intravenous Infusion Pumps Market – Macro Economic Scenario
5. Global Intravenous Infusion Pumps Market Size and Growth
.
.
.
26. South America Intravenous Infusion Pumps Market
27. Brazil Intravenous Infusion Pumps Market
28. Middle East Intravenous Infusion Pumps Market
29. Africa Intravenous Infusion Pumps Market
30. Intravenous Infusion Pumps Market Competitive Landscape And Company Profiles
Top Major Players:
- Braun Melsungen AG
- Baxter International Inc
- Medtronic PLC
- Fresenius Kabi AG
- Smiths Medical Inc
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
